Setting a new milestone, the Indian government on November 20 launched an indigenous CRISPR-based gene therapy for Sickle Cell Disease, which particularly affects India's tribal population. 

The low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great tribal freedom fighter, was launched by Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh.